Analysts forecast that Cantel Medical Corp. (NYSE:CMD) will announce $238.60 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for Cantel Medical’s earnings, with estimates ranging from $236.70 million to $240.50 million. Cantel Medical posted sales of $228.85 million in the same quarter last year, which suggests a positive year over year growth rate of 4.3%. The business is expected to announce its next earnings report on Thursday, September 26th.
On average, analysts expect that Cantel Medical will report full year sales of $917.30 million for the current financial year, with estimates ranging from $915.30 million to $919.30 million. For the next year, analysts forecast that the firm will report sales of $985.20 million, with estimates ranging from $977.70 million to $992.70 million. Zacks’ sales averages are a mean average based on a survey of research firms that cover Cantel Medical.
Cantel Medical (NYSE:CMD) last posted its quarterly earnings data on Tuesday, June 4th. The company reported $0.55 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.55. The business had revenue of $228.55 million during the quarter, compared to analysts’ expectations of $225.95 million. Cantel Medical had a net margin of 6.95% and a return on equity of 15.52%.
Shares of Cantel Medical stock traded up $0.04 on Friday, hitting $88.72. The stock had a trading volume of 86,593 shares, compared to its average volume of 268,634. The stock has a 50 day moving average of $83.71 and a 200 day moving average of $75.01. Cantel Medical has a twelve month low of $63.47 and a twelve month high of $99.68. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.45 and a current ratio of 2.33. The firm has a market capitalization of $3.72 billion, a P/E ratio of 35.35 and a beta of 1.11.
The company also recently disclosed a Semi-Annual dividend, which was paid on Wednesday, July 31st. Stockholders of record on Wednesday, July 17th were paid a $0.10 dividend. The ex-dividend date was Tuesday, July 16th. Cantel Medical’s dividend payout ratio is currently 7.97%.
Cantel Medical Company Profile
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
Recommended Story: What is Considered a Good Return on Equity (ROE)?
Get a free copy of the Zacks research report on Cantel Medical (CMD)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.